Ledger.Open graph →
SEC Form D · filed January 20, 2016

RespireRx Pharmaceuticals Inc

Offering
$2.5M
Sold
$100K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLEN ROCK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Kathryn E. Macfarlane · Glen Rock, NJDirectorJames S. Manuso · Dublin, CAExec · DirectorRichard E. Purcell · Glen Rock, NJExecRobert N. Weingarten · Glen Rock, NJExec · DirectorSponsor Colony Hills Capital, LLC · Wilbraham, MADirectorRobert N. Weingarten · Glen Rock, NJExec · DirectorJames S. Manuso · Glen Rock, NJExec · DirectorAmrit Shahzad · Beverly, MADirectorJames E. Sapirstein · Glen Rock, NJDirectorRichard E. Purcell · Glen Rock, NJExecArnold S. Lippa · Glen Rock, NJExec · DirectorGlenn R. Hanson · Wilbraham, MAExec · DirectorJeff E. Margolis · Glen Rock, NJExec · DirectorAndrew F. St Pierre · Burlington, MAExec · DirectorKathryn E. Macfarlane · Glen Rock, NJDirectorArnold S. Lippa · Glen Rock, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗